Immunotherapy advances for glioblastoma

Survival for patients with glioblastoma, the most common high-grade primary CNS tumor, remains poor despite multiple therapeutic interventions including intensifying cytotoxic therapy, targeting dysregulated cell signaling pathways, and blocking angiogenesis. Exciting, durable clinical benefits have...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Reardon, David A., Freeman, Gordon, Wu, Catherine, Chiocca, E. Antonio, Wucherpfennig, Kai W., Wen, Patrick Y., Fritsch, Edward F., Curry, William T., Sampson, John H., Dranoff, Glenn
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2014
Konular:
Reviews
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4201077/
https://ncbi.nlm.nih.gov/pubmed/25190673
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou212
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller